PARDES-HANNA, Israel, June 18, 2019 -- RedDress’s ActiGraft is one of the medical innovations that was showcased in front of thousands of healthcare providers at Premier Inc.’s 2019 Breakthroughs Conference and Exhibition on June 18.
RedDress’s ActiGraft was debuted during the conference’s 11th annual Innovation Celebration, an event recognizing advancements in healthcare and highlighting suppliers dedicated to furthering innovation and improving patient outcomes in the industry. “RedDress shares Premier’s commitment to providing valuable products to our alliance members that are safe, high-quality and cost-effective,” said David A. Hargraves, Senior Vice President of Supply Chain, Premier. “These innovations can truly benefit providers in our shared work to transform healthcare.” Clinicians and other health system members of Premier selected ActiGraft to be showcased at the Innovation Celebration due to its uniqueness, ability to have an impact on unmet clinical needs and potential to improve patient care. ActiGraft, based on RedDress’ proprietary patented technology, is the first wound care product that enables health care providers to produce—in real time—in vitro blood clots from a patient’s whole blood. Once applied, the blood clot tissue serves as a protective covering and supports wound healing processes which naturally occur in the patient's body. “ActiGraft: There is No Substitute” Any supplier, regardless of whether the company is contracted with Premier, can be considered for participation in the Innovation Celebration. Premier contracts with more than 1,400 suppliers. For more detailed information, including a video of ActiGraft, visit:


Premier Inc. is a leading healthcare improvement company, uniting an alliance of more than 4,000 U.S. hospitals and health systems and approximately 165,000 other providers and organizations to transform healthcare. With integrated data and analytics, collaboratives, supply chain solutions, and consulting and other services, Premier enables better care and outcomes at a lower cost.


RedDress is committed to improving the health and lives of patients around the world by revolutionizing the way we treat chronic wounds. Our innovative products are advanced, biologic wound care solutions that recreate the natural wound healing processes of the body. Founded in 2009 by Dr. Igal Kushnir MD and Alon Kushnir with the goal of developing more effective, natural, and economically viable treatments for chronic wounds, we’re excited to announce our latest innovation—ActiGraft.